Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
Boston Scientific Corp (BSX)  
$73.17 0.09 (0.12%) as of 4:30 Fri 4/26


Download
   
Exchange: New York Stock Exchange
Security Type: Common
Shares Out: 1,430,000,000
Market Cap: 104.63(B)
Last Volume: 8,786,292 Avg Vol: 8,469,733
52 Week Range: $48.64 - $73.26
Level I Sector: Health Care
Level II Sector: Health Services
Level III Sector: Medical Instruments & Supplies

Member Indexes:

    S&P COMPOSITE 1500     NYSE COMPOSITE
    S&P 500

Rankings:

     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  297
Guru Rank Value     : 4.1
Guru Occurances    : 2

 

            6 Months   1 Year   2 Year  
 
Company Profile   Boston Scientific develops, manufactures and markets medical devices. Co.'s Medical Surgical segment consist of: Endoscopy, which develops and manufactures devices to diagnose and treat a range of gastrointestinal and pulmonary conditions; and Urology and Pelvic Health, which develops and manufactures devices to treat various urological and pelvic conditions. Co.'s Rhythm and Neuro segment includes: Cardiac Rhythm Management, which develops and manufactures implantable devices to treat cardiac abnormalities; and Electrophysiology, which develops and manufactures medical technologies used in the diagnosis and treatment of rate and rhythm disorders of the heart.


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 86,763 367,796 891,893 1,852,495
Total Sell Value $5,815,387 $21,391,604 $49,075,093 $90,475,166
Total People Sold 6 8 11 13
Total Sell Transactions 9 19 36 69
End Date 2024-01-28 2023-10-27 2023-04-28 2022-04-28

   
Records found: 1823
  Page 20 of 73  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Onuscheck John Michael SVP & President, EMEA   •       –      –    2012-02-28 4 D $6.36 $14,577 D/D (2,292) 53,843     -
   Onuscheck John Michael SVP & President, EMEA   •       –      –    2012-02-28 4 OE $0.00 $0 D/D 5,238 56,135     -
   Kucheman William Chief Executive Officer   •       •      –    2012-02-28 4 D $6.36 $28,162 D/D (4,428) 102,525     -
   Kucheman William Chief Executive Officer   •       •      –    2012-02-28 4 OE $0.00 $0 D/D 13,967 106,953     -
   Lance Jean Fitterer SVP & Chief Compliance Officer   •       –      –    2012-02-28 4 D $6.36 $8,720 D/D (1,371) 72,075     -
   Lance Jean Fitterer SVP & Chief Compliance Officer   •       –      –    2012-02-28 4 OE $0.00 $0 D/D 4,190 73,446     -
   Capello Jeffrey D EVP & Chief Financial Officer   •       –      –    2012-02-28 4 D $6.36 $21,122 D/D (3,321) 128,805     -
   Capello Jeffrey D EVP & Chief Financial Officer   •       –      –    2012-02-28 4 OE $0.00 $0 D/D 10,475 132,126     -
   Dawkins Keith D EVP, Global Chief Med. Off.   •       –      –    2012-02-28 4 D $6.36 $9,858 D/D (1,550) 61,965     -
   Dawkins Keith D EVP, Global Chief Med. Off.   •       –      –    2012-02-28 4 OE $0.00 $0 D/D 4,889 63,515     -
   Burns Brian R EVP - Global Quality & Reg Aff   •       –      –    2012-02-28 4 D $6.36 $15,493 D/D (2,436) 79,418     -
   Burns Brian R EVP - Global Quality & Reg Aff   •       –      –    2012-02-28 4 OE $0.00 $0 D/D 7,682 81,854     -
   Nanavaty Maulik SVP & Pres, Neuromodulation   •       –      –    2012-02-28 4 D $6.36 $3,873 D/D (609) 57,708     -
   Nanavaty Maulik SVP & Pres, Neuromodulation   •       –      –    2012-02-28 4 OE $0.00 $0 D/D 2,270 58,317     -
   Fitzgerald Joseph Michael SVP & President, CRM   •       –      –    2012-02-28 4 D $6.36 $7,263 D/D (1,142) 70,590     -
   Fitzgerald Joseph Michael SVP & President, CRM   •       –      –    2012-02-28 4 OE $0.00 $0 D/D 3,492 71,732     -
   Nanavaty Maulik SVP & Pres, Neuromodulation   •       –      –    2012-02-24 4 D $6.25 $4,044 D/D (647) 56,047     -
   Nanavaty Maulik SVP & Pres, Neuromodulation   •       –      –    2012-02-24 4 OE $0.00 $0 D/D 2,109 56,694     -
   Neumann Lawrence R SVP and Pres, Emerging Markets   •       –      –    2012-02-24 4 D $6.25 $8,719 D/D (1,395) 73,423     -
   Neumann Lawrence R SVP and Pres, Emerging Markets   •       –      –    2012-02-24 4 OE $0.00 $0 D/D 4,217 74,818     -
   Lance Jean Fitterer SVP & Chief Compliance Officer   •       –      –    2012-02-24 4 D $6.25 $6,631 D/D (1,061) 69,256     -
   Lance Jean Fitterer SVP & Chief Compliance Officer   •       –      –    2012-02-24 4 OE $0.00 $0 D/D 3,012 70,317     -
   Kucheman William Chief Executive Officer   •       •      –    2012-02-24 4 D $6.25 $5,969 D/D (955) 92,986     -
   Kucheman William Chief Executive Officer   •       •      –    2012-02-24 4 OE $0.00 $0 D/D 3,012 93,941     -
   Fitzgerald Joseph Michael SVP & President, CRM   •       –      –    2012-02-24 4 OE $6.25 $2,713 D/D 434 68,240     -

  1823 Records found
  Previous  20  21  22  23  24  25  26  27  28  29  Next   
  Page 20 of 73
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed